FORM by GBY vs MadeMed
Two GLP-1 desks, one scoreboard. We put FORM by GBY and MadeMed head-to-head on the published Brief Score — the same six factors, scored the same way.
MadeMed
The verdict
MadeMed takes this head-to-head.
MadeMed scores 86 to 67 on our six-factor Brief Score — Publishes a price for every dose of every route — which makes it easy to brief, and expensive if you stay low.
That doesn't make FORM by GBY a bad call — it's best for readers who want the widest single-account menu and are willing to complete intake to learn what the branded and adjacent-care lines actually cost. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| FORM by GBY | MadeMed | |
|---|---|---|
| Brief Score | 67/100 (C) | 86/100 (B) |
| Semaglutide | $299/mo (compounded, no dose tiers published) | $239/mo injectable · $219/mo sublingual (quarterly) |
| Tirzepatide | Not disclosed (Zepbound membership offered, drug cost not published) | $399/mo injectable · $299/mo sublingual (quarterly) |
| Coverage | 48 states + DC (excludes Alaska, Mississippi) | 40 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Yes |
| On the tracker | Newnew to the tracker, no prior reading | Stableprice stable |
FORM by GBY: First reading — one real price (compounded sema $299); everything else, including the advertised Wegovy "$95," is a membership fee or undisclosed.
MadeMed: Publishes one price per route that holds at every dose — the cleanest dose-to-price mapping we track.
● Not sold on either?
CoreAge Rx tops the whole board at 94/100.
The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.